Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis
Study reaffirms the Foundation's commitment to advance solutions to the growing challenge of antibiotic resistance and evaluate the use of phage to treat infections for people with CF
Nonprofit issues challenge to accelerate treatments for every person with CF
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Funding will support improved detection, diagnosis, prevention, and treatment of infections related to cystic fibrosis.
Program Aimed at Advancing Search for Therapies Targeting Most Common Mutation of CF
Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies